Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126764652 | 12676465 | 2 | F | 20130109 | 20160921 | 20160823 | 20160930 | EXP | ZA-GLAXOSMITHKLINE-ZA2016121903 | GLAXOSMITHKLINE | 29.00 | YR | F | Y | 77.90000 | KG | 20160930 | MD | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126764652 | 12676465 | 1 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 300 MG, QD | 78900 | MG | U | 0 | 300 | MG | TABLET | QD | |||
| 126764652 | 12676465 | 2 | SS | EFAVIRENZ + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZEMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 126764652 | 12676465 | 3 | SS | Efavirenz | EFAVIRENZ | 1 | Unknown | 600 MG, QD | 157800 | MG | U | 0 | 600 | MG | QD | ||||
| 126764652 | 12676465 | 4 | PS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | 300 MG, QD | 78900 | MG | U | 20564 | 300 | MG | QD | ||||
| 126764652 | 12676465 | 5 | SS | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Unknown | U | 0 | ||||||||||
| 126764652 | 12676465 | 6 | SS | Aluminium Hydroxide | ALUMINUM HYDROXIDE | 1 | Unknown | U | 0 | ||||||||||
| 126764652 | 12676465 | 7 | SS | MAGNESIUM TRISILICATE | MAGNESIUM TRISILICATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126764652 | 12676465 | 1 | HIV infection |
| 126764652 | 12676465 | 2 | HIV infection |
| 126764652 | 12676465 | 3 | HIV infection |
| 126764652 | 12676465 | 4 | HIV infection |
| 126764652 | 12676465 | 5 | Product used for unknown indication |
| 126764652 | 12676465 | 6 | Product used for unknown indication |
| 126764652 | 12676465 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126764652 | 12676465 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126764652 | 12676465 | Caesarean section | |
| 126764652 | 12676465 | Exposure during pregnancy | |
| 126764652 | 12676465 | Normal newborn |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126764652 | 12676465 | 1 | 20110917 | 20120606 | 0 | |
| 126764652 | 12676465 | 2 | 20120606 | 0 | ||
| 126764652 | 12676465 | 3 | 20110917 | 20120606 | 0 | |
| 126764652 | 12676465 | 4 | 20110917 | 20120606 | 0 |